Search Results

FILTER BY

1 - 12 of 45 matches

Sort by:
  • NewsDaily News

    IVUS in Complex PCI Improves Outcomes, Even for Less-Experienced Operators

    Caitlin E. Cox

    July 27, 2023

  • NewsConference NewsEuroPCR 2023

    For Bifurcation Lesions, It’s OK to Start With Just One Stent: EBC Trials

    Caitlin E. Cox

    May 17, 2023

  • NewsConference NewsAHA 2022

    Cangrelor After Ticagrelor Pretreatment in ACS Might Be OK: SWAP-5

    Yael L. Maxwell

    November 11, 2022

  • PresentationTCT 2022

    TCT 46: Prehospital crushed versus integral prasugrel loading dose in patients presenting with anterior ST-segment elevation myocardial infarction – A COMPARE CRUSH subanalysis

    Presenter:  

    Rosanne Vogel

    September 17, 2022

  • PresentationTCT 2022

    TCT 28: Pharmacodynamic response, early reperfusion and clinical outcomes to pre-hospital prasugrel administration in diabetic patients presenting with STEMI – A COMPARE CRUSH subanalysis

    Presenter:  

    Rosanne Vogel

    September 17, 2022

  • PresentationTCT 2022

    TCT 23: Influence of the circadian clock on the pharmacodynamic effect of prasugrel in patients presenting with ST-segment elevation myocardial infarction – A COMPARE CRUSH subanalysis

    Presenter:  

    Rosanne Vogel

    September 17, 2022

  • NewsDaily News

    Longer-Term Data Still Worrisome for Impella-Treated AMICS Patients

    Caitlin E. Cox

    July 20, 2022

  • NewsConference NewsEuroPCR 2022

    Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot

    Michael O'Riordan

    May 23, 2022

  • NewsConference NewsTCT 2021

    Crushed Prasugrel Loading Dose Still No Benefit at 1 Year in COMPARE CRUSH

    Yael L. Maxwell

    October 15, 2021

  • PodcastTCTMD Talking Points

    The COMPARE CRUSH Trial

    September 22, 2021

  • NewsDaily News

    Crushed Prasugrel in the Ambulance Ups Platelet Inhibition in Primary PCI

    Yael L. Maxwell

    June 22, 2021

  • NewsConference NewsEuroPCR 2021

    Provisional Stenting Noninferior to Planned Two-Stent Strategy for Left Main Disease: EBC MAIN

    L.A. McKeown

    May 21, 2021